COVID-19 Vaccine: A comprehensive status report
Review
[키워드] ADE, Antibody-dependent enhancement
age
angiotensin
antibodies
approach
ARDS, acute respiratory distress syndrome
benefit
China
clinical
clinical trials
co-morbid conditions
Convalescent plasma therapy
CoV, coronavirus
COVID-19
COVID-19 pandemic
COVID-19 vaccine
COVID-19 vaccine development
COVID-19, Coronavirus disease 2019
CP, convalescent plasma
curtail
DC, Dendritic Cells
DPP4, Dipeptidyl Peptidase
effective
Efficacy
effort
elicit
estimates
frontline healthcare worker
Genetic
hACE2
hACE2, Human Angiotensin- Converting Enzyme 2
Health
host cell
immunization
include
individual
involved
LAV, Live Attenuated Vaccine
limitations
LNP, Lipid Nanoparticle
MERS
MERS-CoV, Middle East respiratory syndrome coronavirus
monoclonal antibodies
monoclonal antibody
nAb, Neutralizing Antibody
Novel coronavirus
NSP, Non-structural Proteins
NTD, N Terminal Domain
outbreak
pandemic
Pathogenesis
platform
protective immunity
Protein subunit vaccines
RBD, Receptor Binding Domains
RBM, receptor binding motif
reactivity
receptor
SARS-CoV
SARS-CoV-2
SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2
SARS-CoV, severe acute respiratory syndrome coronavirus
SARS, Severe acute respiratory syndrome
Scientific community
Spanish flu
the disease
TLR, Toll-like receptor
TMPRSS2, Transmembrane Protease Serine 2
Vaccination strategy
Vaccine
Vaccine development
vaccinee
Vaccines
virus
VLP, virus-like particle
WHO
[DOI] 10.1016/j.virusres.2020.198114 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.virusres.2020.198114 PMC 바로가기 [Article Type] Review